Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-05-25

Clinical Trial Update: TAMIS-IPAA vs. Lap-IPAA for Ulcerative Colitiis [NA]

View source ↗

Summary

This clinical trial entry compares TAMIS-IPAA vs Lap-IPAA for ulcerative colitis, sponsored by Jinling Hospital, with the trial status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Jinling Hospital, China | Conditions: Ulcerative Colitis, Postoperative Complications | NA | Status: UNKNOWN